EPISBS Stock Overview
A medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Episurf Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.24 |
| 52 Week High | SEK 0.24 |
| 52 Week Low | SEK 0.24 |
| Beta | 1.03 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -87.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| EPISBS | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | 0.8% | -0.9% |
| 1Y | n/a | -7.0% | 9.8% |
Return vs Industry: Insufficient data to determine how EPISBS performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how EPISBS performed against the UK Market.
Price Volatility
| EPISBS volatility | |
|---|---|
| EPISBS Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.7% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in GB Market | 10.5% |
| 10% least volatile stocks in GB Market | 2.5% |
Stable Share Price: EPISBS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine EPISBS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 26 | Pal Ryfors | episurf.com |
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient’s knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint. The company also provides Episealer Talus, a solution for the treatment of bone and cartilage defects in the talus bone of the ankle joint; Epioscopy to identify and visualize femoral knee joint cartilage and bone lesions, and tibia, as well as defects on the cruciate ligaments and menisci; Epiguide, a surgical drill guide; and µiFidelity, a web platform for order management, communication, personalized design, and surgical pre-planning.
Episurf Medical AB (publ) Fundamentals Summary
| EPISBS fundamental statistics | |
|---|---|
| Market cap | SEK 97.33m |
| Earnings (TTM) | -SEK 84.70m |
| Revenue (TTM) | SEK 11.70m |
8.3x
P/S Ratio-1.1x
P/E RatioIs EPISBS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EPISBS income statement (TTM) | |
|---|---|
| Revenue | SEK 11.70m |
| Cost of Revenue | SEK 52.40m |
| Gross Profit | -SEK 40.70m |
| Other Expenses | SEK 44.00m |
| Earnings | -SEK 84.70m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 25, 2024
| Earnings per share (EPS) | -0.13 |
| Gross Margin | -347.86% |
| Net Profit Margin | -723.93% |
| Debt/Equity Ratio | 0% |
How did EPISBS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/09/30 07:25 |
| End of Day Share Price | 2024/07/03 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Episurf Medical AB (publ) is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yilmaz Mahshid | Pareto Securities |
| Anders Hedlund | Redeye |
| John Westborg | Redeye |